ArticleOPEN ACCESS

Checkpoint ahead — be prepared to stop!

Nature Reviews Cancer
DOI: 10.1038/s41568-018-0096-2
1Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Two studies published in Cell have characterized the inhibitory immune receptor NKG2A expressed on cytotoxic lymphocytes, such as natural killer cells and CD8 + T cells, as a novel checkpoint for cancer immunotherapy.

Cite

CITATION STYLE

APA

Dart, A. (2019, February 1). Checkpoint ahead — be prepared to stop! Nature Reviews Cancer. Nature Publishing Group. https://doi.org/10.1038/s41568-018-0096-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free